IIPLA News
Thursday, May 14, 2026

Moleculin Biotech Expands Global Patent Portfolio with Hong Kong Approval for Annamycin Reconstitution Method

New Hong Kong patent strengthens Moleculin’s intellectual property protection ahead of pivotal Phase 3 clinical data release for Annamycin

IIPLA News Deskanonymous access0 articles left this week
Moleculin Biotech Expands Global Patent Portfolio with Hong Kong Approval for Annamycin Reconstitution Method
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

Moleculin Biotech has secured a key patent in Hong Kong covering its proprietary method of reconstituting liposomal Annamycin, extending its intellectual property protection through 2040. This milestone enhances the company’s global exclusivity strategy as it prepares for the upcoming release of Phase 3 clinical trial…
Share This Article
Ready-to-post copy includes the article link.

Moleculin Biotech Expands Global Patent Portfolio with Hong Kong Approval for Annamycin Reconstitution Method Moleculin Biotech has secured a key patent in Hong Kong covering its proprietary method of reconstituting liposomal Annamycin, extending its intellectual property protection through 2040. This milestone enhances the com... Read the full IIPLA article: https://iipla.org/news/moleculin-biotech-expands-global-patent-portfolio-with-hong-kong-approval-for-annamycin-reconstitution-method

Related Coverage

Continue in the newsroom

Back to newsroom
TrademarksGlobal

Taylor Swift Moves to Trademark Her Voice and Image Amid Rising AI Concerns

In response to the rapid growth of AI-generated content, global music icon Taylor Swift has initiated trademark applications to protect her voice and image. This strategic move aims to prevent unauthorized commercial use of her persona in AI-driven media and advertising, reflecting broader industry concerns about inte…

Thursday, May 14, 2026